Time in Range (TIR), a new statistic introduced by CGM systems. It measures how long a person's blood glucose levels remain within a particular range. According to Professor Kar, TIR provides "a ...

Fourteen-day continuous glucose monitoring (CGM) traces added to Diabetes Control and Complications Trial (DCCT) data can predict microvascular diabetes complications similarly to glycated hemoglobin.

This innovative approach aims to assess the association between CGM-derived time-in-range (TIR) metrics and the risk of microvascular complications in individuals with Type 1 diabetes (T1D ...

Time in range was similar among pediatric patients with type 1 diabetes who used either the Insulet Omnipod 5 or the Tandem Control IQ.

However, the use of continuous glucose monitoring is on the rise and ... These readings included the time spent in "tight range" (between 70 and 140 mg/DL) as well as the time spent above 140 ...

In a new study, researchers found that time-in-range for healthy blood sugar could be a viable marker of glycemic control and potentially could be used to predict complications of type 1 diabetes.

However, the use of continuous glucose monitoring is on the rise and ... These readings included the time spent in "tight range" (between 70 and 140 mg/DL) as well as the time spent above 140 ...

However, the use of continuous glucose monitoring is on the rise and ... These readings included the time spent in "tight range" (between 70 and 140 mg/DL) as well as the time spent above 140 ...

This study reinforces the significance of intensive glycaemic control and is a paradigm shift in managing the disease and its complications.